Thermo Fisher Scientific Inc. TMO
NYSE
| 09/26/2026 | 06/27/2026 | 03/28/2026 | 12/31/2025 | 09/27/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.50% | 7.36% | 9.56% | 7.32% | -0.86% |
| Total Depreciation and Amortization | 24.81% | 19.39% | 4.11% | -1.89% | -11.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.79% | 97.19% | -26.56% | 156.45% | 127.05% |
| Change in Net Operating Assets | 58.65% | 41.46% | 21.96% | -24.75% | -446.67% |
| Cash from Operations | 13.89% | 51.89% | 64.87% | 5.08% | 3.37% |
| Capital Expenditure | -8.17% | -53.06% | -3.87% | 3.13% | -48.53% |
| Sale of Property, Plant, and Equipment | -75.00% | 300.00% | -25.00% | 58.82% | -80.00% |
| Cash Acquisitions | 99.88% | -- | -- | -- | -28.90% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -309.24% | 12,100.00% | 257.06% | 175.16% | 261.86% |
| Cash from Investing | 98.13% | 156.94% | -1,600.38% | 4,355.00% | -15.23% |
| Total Debt Issued | -100.00% | -- | 98.13% | -- | -- |
| Total Debt Repaid | -85.43% | 50.57% | -68.50% | 48.60% | 46.07% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -- | -50.00% | 96.30% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.75% | -8.02% | -8.72% | -8.72% | -8.67% |
| Other Financing Activities | 5,550.00% | 83.33% | -11.11% | 635.29% | -105.97% |
| Cash from Financing | -68.20% | -58.53% | 1,171.57% | 196.18% | 46.89% |
| Foreign Exchange rate Adjustments | 84.00% | -68.49% | 110.81% | 97.80% | -142.86% |
| Miscellaneous Cash Flow Adjustments | 100.00% | -- | -200.00% | -- | -- |
| Net Change in Cash | 153.94% | 89.33% | -5,099.24% | 1,348.89% | -6.80% |